- IDRA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $15.0 million.
- IDRA has traded 57,606 shares today.
- IDRA is up 3.1% today.
- IDRA was down 9.9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in IDRA with the Ticky from Trade-Ideas. See the FREE profile for IDRA NOW at Trade-Ideas More details on IDRA: Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. Currently there are 2 analysts that rate Idera Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Idera Pharmaceuticals has been 1.2 million shares per day over the past 30 days. Idera has a market cap of $332.1 million and is part of the health care sector and drugs industry. The stock has a beta of 3.18 and a short float of 12.4% with 1.96 days to cover. Shares are down 17.1% year-to-date as of the close of trading on Friday.